Study to Evaluate the Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED) (SDP-4-CS202)
Status:
Completed
Trial end date:
2021-02-10
Target enrollment:
Participant gender:
Summary
SDP-4-CS202 is a Phase 2, multicenter, double-masked, randomized, vehicle-controlled,
parallel group study designed to evaluate the ocular efficacy of SDP-4 ophthalmic solution in
subjects with moderate to severe dry eye disease over an 8-week treatment period. Once
concentration (1%) of SDP-4 ophthalmic solution will be given in a parallel group to vehicle
via topical ocular instillation BID.